Help people feel better and live longer!
Our mission

Help people feel better and live longer!

About company

ACADEMPHARM

about-img-3-min

The pharmaceutical quality system functioning at the enterprise is developed on the basis of GMP requirements

about-img-1-min

Today ACADEMPHARM is a dynamically developing high-tech state-owned pharmaceutical enterprise of production and distribution of medications and biologically active additives of high quality. In spite of the young age for the pharmaceutical industry, ACADEMPHARM has already filled a niche on the domestic market and continues to expand it. In 2011 ACADEMPHARM produced 6 kinds of drug products, and in 2021 – already 40.

Areas of activity:
Laboratory pharmaceutical research.
Industrial production of medicines and other pharmaceutical products, vitamin, vitamin-mineral and metabolic complexes, nutraceuticals.
Contract pharmaceutical production.
Our preparations

Topical drugs in 2021

AlginoMAX
AlginoMAX
Tablets
No prescription
Flustop
Flustop
Capsules
No prescription

Antiviral drug

Rivaxan
Rivaxan
Tablets
On prescription
Ursaklin
Ursaklin
Capsules
On prescription

Bile acid drug

SilaMEN
SilaMEN
Tablets
No prescription

An effective and safe drug used in the treatment of erectile function

our history

History of the company ACADEMPHARM

2010

The first release of industrial production was carried out in 2010. Due to the epidemic of influenza virus A (H1N1) by order of the Ministry of Health of the Republic of Belarus, the production of the antiviral drug “Flustop” («Флустоп») in the form of hard gelatin capsules was implemented. The state-owned enterprise ACADEMPHARM is the only manufacturer of this drug product in the Republic of Belarus.

2011-2012

In 2012, all units of production equipment and production of the forms of presentation such as hard gelatin capsules, tablets, and powders in bags were implemented.

2013-2014

In 2014, in accordance with the Decree of the President of the Republic of Belarus No. 174 “On Certain Measures for the Development of the Pharmaceutical Industry” in 2013-2014, a new administration and amenity building with a storage facility was placed into operation. The area of new production facilities is more than 400 sq.m.

2015-2016

In 2015-2016, storage facilities were placed into operation for storage of excipients and active ingredients, packaging materials and finished products in accordance with the GMP requirements. The total storage area of the state-owned enterprise ACADEMPHARM is more than 1250 sq.m.

2017

In 2017, the company concluded the contracts for the supply of a purified water production system with the company LLC “Thermodistillation RV” (ООО «Термодистилляция РВ») (Ukraine), a film coating machine for tablets produced by Nicomac (Italy), a roller compactor produced by the company AlexanderwerkAG (Germany)

2018

On August 6, 2018, the grand opening ceremony of the landscape complex was held on the occasion of the start of construction of the YUSUF HAMID PHARMA R&D CENTER on the basis of the state-owned enterprise ACADEMPHARM. Indian pharmaceutical company Cipla Limited, headed by the chairman of the company Yusuf Hwaja Hamid, invested $ 1 million in the construction of this research and technology center.

2019

In 2019, the number of the developed drug products of the enterprise is over 40 drugs of various pharmacotherapeutic groups. The range of industrial production in comparison with the start of production increased by a factor of more than 20 times, in monetary terms - by a factor of more than 30 times. In 2018, with the participation of foreign investments further modernization of production was started.

2020

2020 has become a special year for the whole world in connection with the coronavirus infection pandemic caused by the SARS-CoV-2 (Covid-19) coronavirus. This challenge has required many companies to make quick and effective solutions to help the public and doctors in such an environment. The team of the ACADEMPHARM enterprise has made every effort to put on the market of the Republic of Belarus the drug Rivaksan, necessary for patients with coronavirus infection to prevent thrombus formation, as quickly as possible. This was especially important, since the only drug in this group was practically absent in the pharmacies of our country.

We express our THANKS to all healthcare professionals for their dedicated work in the harshest conditions of the coronavirus pandemic!